These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 11854455

  • 1. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis.
    Kim MJ, Cardiff RD, Desai N, Banach-Petrosky WA, Parsons R, Shen MM, Abate-Shen C.
    Proc Natl Acad Sci U S A; 2002 Mar 05; 99(5):2884-9. PubMed ID: 11854455
    [Abstract] [Full Text] [Related]

  • 2. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.
    Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, Abate-Shen C.
    Cancer Res; 2002 Jun 01; 62(11):2999-3004. PubMed ID: 12036903
    [Abstract] [Full Text] [Related]

  • 3. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases.
    Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM.
    Cancer Res; 2003 Jul 15; 63(14):3886-90. PubMed ID: 12873978
    [Abstract] [Full Text] [Related]

  • 4. Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.
    Kladney RD, Cardiff RD, Kwiatkowski DJ, Chiang GG, Weber JD, Arbeit JM, Lu ZH.
    Cancer Res; 2010 Nov 01; 70(21):8937-47. PubMed ID: 20940396
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D inhibits the formation of prostatic intraepithelial neoplasia in Nkx3.1;Pten mutant mice.
    Banach-Petrosky W, Ouyang X, Gao H, Nader K, Ji Y, Suh N, DiPaola RS, Abate-Shen C.
    Clin Cancer Res; 2006 Oct 01; 12(19):5895-901. PubMed ID: 17020998
    [Abstract] [Full Text] [Related]

  • 6. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.
    Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H.
    Cancer Cell; 2003 Sep 01; 4(3):209-21. PubMed ID: 14522255
    [Abstract] [Full Text] [Related]

  • 7. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
    Song H, Zhang B, Watson MA, Humphrey PA, Lim H, Milbrandt J.
    Oncogene; 2009 Sep 17; 28(37):3307-19. PubMed ID: 19597465
    [Abstract] [Full Text] [Related]

  • 8. MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells.
    Iwata T, Schultz D, Hicks J, Hubbard GK, Mutton LN, Lotan TL, Bethel C, Lotz MT, Yegnasubramanian S, Nelson WG, Dang CV, Xu M, Anele U, Koh CM, Bieberich CJ, De Marzo AM.
    PLoS One; 2010 Feb 25; 5(2):e9427. PubMed ID: 20195545
    [Abstract] [Full Text] [Related]

  • 9. NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss.
    Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, Gleave ME, Witte ON, Liu X, Wu H.
    Cancer Cell; 2006 May 25; 9(5):367-78. PubMed ID: 16697957
    [Abstract] [Full Text] [Related]

  • 10. Pten, a protean tumor suppressor.
    Mutter GL.
    Am J Pathol; 2001 Jun 25; 158(6):1895-8. PubMed ID: 11395362
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Id4 deficiency attenuates prostate development and promotes PIN-like lesions by regulating androgen receptor activity and expression of NKX3.1 and PTEN.
    Sharma P, Knowell AE, Chinaranagari S, Komaragiri S, Nagappan P, Patel D, Havrda MC, Chaudhary J.
    Mol Cancer; 2013 Jun 21; 12():67. PubMed ID: 23786676
    [Abstract] [Full Text] [Related]

  • 14. Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.
    Bowen C, Ostrowski MC, Leone G, Gelmann EP.
    Cancer Res; 2019 Aug 15; 79(16):4124-4134. PubMed ID: 31213464
    [Abstract] [Full Text] [Related]

  • 15. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
    Blando J, Portis M, Benavides F, Alexander A, Mills G, Dave B, Conti CJ, Kim J, Walker CL.
    Am J Pathol; 2009 May 15; 174(5):1869-79. PubMed ID: 19395652
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
    Anderson PD, McKissic SA, Logan M, Roh M, Franco OE, Wang J, Doubinskaia I, van der Meer R, Hayward SW, Eischen CM, Eltoum IE, Abdulkadir SA.
    J Clin Invest; 2012 May 15; 122(5):1907-19. PubMed ID: 22484818
    [Abstract] [Full Text] [Related]

  • 18. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
    Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C.
    Cancer Res; 2005 Aug 01; 65(15):6773-9. PubMed ID: 16061659
    [Abstract] [Full Text] [Related]

  • 19. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
    Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, van Duijn P, Cleutjens KB, de Krijger R, Krimpenfort P, Berns A, van der Kwast TH, Trapman J.
    Cancer Res; 2005 Jul 01; 65(13):5730-9. PubMed ID: 15994948
    [Abstract] [Full Text] [Related]

  • 20. [PTEN expression in endometrial cancer and the prognosis].
    Kanamori Y, Uegaki K, Kigawa J, Terakawa N.
    Nihon Rinsho; 2004 Oct 01; 62 Suppl 10():406-9. PubMed ID: 15535277
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.